Search Technologies

Showing 1-4 of 4 results found

New Insect Sf9-ET Cell Line for Determining Baculovirus Titers

The National Cancer Institute (NCI) seeks licensing partners for a novel modified insect cell line, Sf9-ET, that can quickly and efficiently determine baculovirus titers during the expression of recombinant proteins from a baculovirus-based protein expression system.

Research Tools

Bac-2-the-Future: An Improved System for Production of Recombinant Baculovirus

The National Cancer Institute (NCI) seeks licensing of Bac-2-the-Future, an improved system for the production of recombinant baculovirus.

Research Tools

A peptide hydrogel for use in vascular anastomosis

Surgery specialists from Johns Hopkins University, in collaboration with researchers at the National Cancer Institute (NCI), developed peptide hydrogel compositions and methods to suture blood vessels during microsurgery. The hydrogels particularly benefit surgeons in whole tissue transplant procedures. The NCI seeks co-development research collaborations for further development of this technology.

Devices

Photoactivatable Lipid-based Nanoparticles as a Vehicle for Dual Agent Delivery

Researchers at the National Cancer Institute (NCI) RNA Biology Laboratory have developed nanoparticles that can deliver an agent (i.e., therapeutic or imaging) and release the agent upon targeted photoactivation allowing for controlled temporal and localized release of the agent.

Therapeutics

You are here

Product Type

Development Stage

Therapeutic Area

Institutes and Centers

Search Technologies

New Insect Sf9-ET Cell Line for Determining Baculovirus Titers

Bac-2-the-Future: An Improved System for Production of Recombinant Baculovirus

A peptide hydrogel for use in vascular anastomosis

Photoactivatable Lipid-based Nanoparticles as a Vehicle for Dual Agent Delivery